In a decisive step towards making its entire oncology product portfolio available in Saudi Arabia, Venus Remedies has secured a marketing authorization from the largest market in the Gulf Cooperation Council (GCE) region for Docetaxel, a widely used chemotherapy drug.
The development comes three months after the company received good manufacturing practices (GNP) certification from the Saudi Food and Drug Authority (SFDA) for all its production facilities at its unit in Baddi, Himachal Pradesh.
Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.
